Galectin Therapeutics Inc. (NASDAQ:GALT) People

Galectin Therapeutics Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Gilbert S. Omenn
Other companies: Amesite Inc. (Director · Since at least Sep 25, 2020); Elicio Therapeutics, Inc. (Director · Feb 4, 2021 – Jun 9, 2022 · Past)
Director · Since at least Dec 14, 2017
Pol F. Boudes
Other companies: Protalix BioTherapeutics, Inc. (de) (Director · Since at least Jan 1, 2020); Amicus Therapeutics Inc (Chief Medical Officer · Jun 15, 2010 – Jun 4, 2012 · Past)
Chief Medical Officer · Mar 2, 2020 – Jan 24, 2024 · Past
Andrew VolosovVice President, Clinical Pharmacology and Pharmacokinetics · Since at least Nov 4, 2026
Benjamin S. CarsonIndependent Director · Since at least Nov 5, 2026
Elissa J. SchwartzIndependent Director · Since at least Aug 31, 2020
Gilbert F. AmelioIndependent Director · Since at least Nov 5, 2026
Harold ShlevinDirector · Since at least Jan 26, 2023
Henry BremIndependent Director · Since at least Mar 31, 2026
Herman Paul PresslerDirector · May 26, 2011 – Mar 12, 2015 · Past
Jack W. CallicuttChief Financial Officer · Since at least Oct 6, 2026
James Theophile GourzisDirector · Feb 8, 2009 – Feb 8, 2009 · Past
Jerald K RomeDirector · Mar 7, 2013 – Mar 28, 2013 · Past
Jim WilkinsHead of CMC and Pharmaceutical Development · Since at least Nov 4, 2026
Joel LewisChief Executive Officer (CEO) and President · Since at least Dec 14, 2017
Kary EldredDirector · Since at least May 22, 2018
Kevin D. FreemanVice Chairman of the Board · Since at least Nov 5, 2026
Khurram JamilChief Medical Officer · Since at least Jul 16, 2026
Richard A. ZordaniIndependent Director · Since at least Nov 5, 2026
Richard A Zordani JrDirector · Since at least Jan 24, 2024
Richard E. UihleinDirector · Since at least Jan 24, 2024
Sharisse BruttoVice President, Project Management · Since at least Nov 5, 2026
Theodore Daniel ZucconiDirector · Dec 14, 2017 – Apr 16, 2018 · Past